Fresenius Medical Care AG (FMS)

Fresenius Medical Care AG Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Fresenius Medical Care AG stock has a target of 25, which predicts an increase of 8.27% from the current stock price of 23.09.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$25	$25	$25	$25
Change	+8.27%	+8.27%	+8.27%	+8.27%

* Price targets were last updated on Jan 6, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Fresenius Medical Care AG is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Macdonald Truist Securities	Truist Securities	Hold Maintains $23 → $25	Hold	Maintains	$23 → $25	+8.27%	Jan 6, 2025
David Macdonald Truist Securities	Truist Securities	Hold Maintains $22 → $23	Hold	Maintains	$22 → $23	-0.39%	Oct 7, 2024
David Macdonald Truist Securities	Truist Securities	Hold Maintains $24 → $22	Hold	Maintains	$24 → $22	-4.72%	Jul 31, 2024
David Macdonald Truist Securities	Truist Securities	Hold Maintains $21 → $24	Hold	Maintains	$21 → $24	+3.94%	May 15, 2024
David Macdonald Truist Securities	Truist Securities	Hold Maintains $24 → $21	Hold	Maintains	$24 → $21	-9.05%	Apr 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

19.46B

Increased by 0.03%

from 19.45B

Revenue Next Year

20.32B

Increased by 4.40%

from 19.46B

EPS This Year

2.85

Increased by 67.59%

from 1.70

EPS Next Year

3.48

Increased by 22.25%

from 2.85

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	17.48B	17.86B	17.62B	19.40B	19.45B	19.46B	20.32B	21.09B
Revenue Growth	5.62%	2.19%	-1.35%	10.10%	0.29%	0.03%	4.40%	3.80%
EPS	3.96	3.96	3.31	2.30	1.70	2.85	3.48	3.91
EPS Growth	-38.60%	-0.01%	-16.44%	-30.60%	-25.97%	67.59%	22.25%	12.37%
Forward PE	-	-	-	-	-	7.74	6.34	5.64
No. Analysts	-	-	-	-	-	25	25	21

Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028	2029
High	20.7B	21.7B	22.5B
Avg	19.5B	20.3B	21.1B
Low	18.7B	19.2B	19.7B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028	2029
High	6.6%	11.4%	10.5%
Avg	0.0%	4.4%	3.8%
Low	-4.0%	-1.6%	-3.0%

EPS Forecast

EPS	2024	2025	2026	2027	2028	2029
High	3.39	4.45	5.33
Avg	2.85	3.48	3.91
Low	1.48	2.02	2.21

EPS Growth

EPS Growth	2024	2025	2026	2027	2028	2029
High	99.5%	56.3%	53.1%
Avg	67.6%	22.2%	12.4%
Low	-13.0%	-29.1%	-36.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.